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A mouse model system for a lethal encephalitis due to influenza has been established by stereotaxic microinjection with
the recombinant R404BP strain of influenza A virus into the olfactory bulb of C57BL/6 mice. The virus infection spread
selectively to neurons in nuclei of the broad areas of the brain parenchyma that have anatomical connections to the olfactory
bulb, leading to apoptotic neurodegeneration. The inflammatory reaction at the extended stage of viral infection involved the
vascular structures affected by induction of inducible nitric oxide synthase and protein nitration; those were related to the
etiology of fatal brain edema. The intraperitoneal administration of amantadine inhibited the viral growth in the brain and
saved mice from the lethal encephalitis. The severity of neuronal loss paralleled the time lag between the virus challenge and
the start of amantadine treatment. Thus, early pharmacological intervention is essential to minimize neurological deficits due
to influenza virus-induced neurodegeneration. © 2002 Elsevier Science (USA)INTRODUCTION
Infections with influenza virus, in some cases, precip-
itate acute encephalitis/encephalopathy especially in
young children (Fujimoto et al., 1998; Kasai et al., 2000;
Kolski et al., 1998; McCullers et al., 1999; Mizuguchi,
1997; Ryan et al., 1999; Sugaya, 2000; Togashi et al.,
2000). This central nervous system (CNS) disease often
leads to a lethal outcome or, if survived, severe neuro-
logical sequelae (Kasai et al., 2000). One to two hundred
children with this disorder are estimated to die during
every influenza season in Japan (Okabe et al., 2000).
Thus, the elucidation of pathomechanisms of the influ-
enza-associated encephalitis/encephalopathy appears
urgent, and effective prophylactic and therapeutic strat-
egies directed against this disease should be re-
searched. However, information concerning such influ-
enza virus-induced CNS disorders is extremely limited in
the absence of appropriate animal models. Accumulat-
ing evidence has suggested the potential neuroinvasive-
ness of influenza virus for humans (Frankova et al., 1977;
Fujimoto et al., 1998; Gamboa et al., 1974; Hakoda and
1 To whom correspondence and reprints should be addressed at
Department of Microbiology, Fukui Medical University School of Med-287Nakatani, 2000; Hayase and Tobita, 1997; Ito et al., 1999;
McCullers et al., 1999; Murphy and Hawkes, 1970; Taka-
hashi et al., 2000; Thraenhart et al., 1975; Togashi et al.,
2000).
Recently, we reported on a nonlethal experimental
virus-animal system where the neurovirulent WSN strain
of influenza A virus, after being introduced into the olfac-
tory bulb, targets several brain structures which are
highly implicated in regulation of behavior and neuropsy-
chiatric disturbances (Mori et al., 1999). Infected neurons
die through mechanisms associated with apoptosis
(Mori and Kimura, 2000, 2001). Here we describe the
successful protection conferred by intraperitoneal ad-
ministration of amantadine hydrochloride against lethal
acute encephalitis induced by the highly neurovirulent
recombinant R404BP strain of influenza A virus (Taka-
hashi et al., 1995) in an experimental mouse system.
From the evidence, it can be inferred that the early
antiviral treatment with amantadine suppresses the pro-
gression of viral infection and inflammation, keeping
neuronal loss to a minimum.
RESULTS
Clinical course
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olfactory bulb of C57BL/6 mice generated lethal acute
encephalitis. The infected mice showed decreased mo-
tor activity, became emaciated, and died by day 13 (Fig.
1). Seizures were not provoked by the tail test. The
limiting dilution study of the inoculum virus revealed that
only one infectious R404BP virus particle was sufficient
to kill a mouse in this experimental system, although the
mean survival day (MSD) became prolonged (Table 1).
Spread of the R404BP virus in the mouse brain
To unveil the potential targets of the R404BP virus in
the mouse brain, a large dose of the virus (105 PFU/
mouse) was introduced into the olfactory bulb. On day 3
after infection, a large number of granule cells became
infected along the needle track in the granular layer of
the ipsilateral main olfactory bulb. Small clusters of in-
fected neurons were found ipsilaterally in the anterior
olfactory nucleus, tenia tecta, and piriform cortex. The
virus also spread from the olfactory bulb, where the
anterior tip of the lateral ventricle reaches, to the cere-
bral ventricle, a small number of ependymal cells being
infected in the lateral and the third ventricles. Infiltration
of mononuclear cells was not overt.
On day 7 after the challenge, the virus targeted several
brain structures which are directly connected to the main
olfactory bulb. The virus infected most granule and mitral
cells in the main olfactory bulb bilaterally, resulting in
efficient transmission of the virus to the olfactory, limbic,
and other brain structures coupled with the olfactory
bulb. Thus, clusters of infected neurons were found in
the tenia tecta, indusium griseum, cingulate cortex, the
anterior olfactory nuclei, piriform cortex, hypothalamus,
horizontal limb of the diagonal band, lateral mammillary
nucleus, amygdaloid complex, raphe, and locus coer-
uleus (Figs. 2 and 3). Furthermore, the virus infection
extended to the ventral tegmental area, substantia nigra,
and oral reticular pontine nucleus. The virus heavily
attacked some circumventricular structures, including
the medial habenular nucleus (Fig. 2). These results
revealed the increased neuroinvasive ability of the
R404BP virus as compared with the original WSN virus
(Mori et al., 1999). At this time point, infected neurons
began to shrink and neurites displayed a bead-like stain-
ing pattern, which can be explained by the process of
neurodegeneration. The cresyl violet staining method
disclosed shrunken neurons with peculiar nuclei in virus-
infected regions of the brain. Neurons infected with the
R404BP virus showed the terminal deoxynucleotidyl
transferase-mediated dUTP nick end-labeling (TUNEL)-
positive signals in a nuclear pattern, indicating that in-
FIG. 1. Survival rate after infection with the recombinant R404BP strain of influenza A virus. The virus (105 PFU) was stereotaxically injected into
the right olfactory bulb of C57BL/6 mice (n  10).
TABLE 1
Survival Rate after Microinjection with Various Doses of the
R404BP Virus into the Right Olfactory Bulb of C57BL/6 Mice
Virus inoculum
(log PFU)
Survival rate
(survivor/total)
Mean
survival daya
5 0/3 9.0 0.5
4 0/3 8.0 0.5
3 0/3 10.3 0.5
2 0/3 10.7 0.7
1 0/3 12.0 0.8
0 0/3 14.3 2.1
1 3/3b —
a Data are expressed as average  SEM.
b Mice were clinically monitored for 28 days after the virus challenge.
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fected neurons were dying through mechanisms associ-
ated with apoptosis (Fig. 4A). On day 9 after being in-
fected with the R404BP virus, the topological distribution
of the virus antigens resembled that of day 7. However,
infected neurons further shrank and fissured into small
bodies. Overall, the virus distribution patterns on day 4
and 10 after the challenge with 10 PFU of the virus
corresponded to those on day 3 and 7 after infection with
105 PFU, respectively.
The postmortem study on day 10 showed heavy neu-
ronal loss in the brain regions targeted by the virus (Fig.
4B). All postmortem brains on days 8, 9, 10, 11, and 12
showed brain edema, while the live brains on day 8, 9,
and 10 did not, suggesting that the brain edema is the
final death-determining factor (Figs. 4C and 4D).
Microinjection of the ultraviolet-inactivated R404BP vi-
rus into the right main olfactory bulb did not produce
encephalitis.
In situ detection of iNOS and NT in the brain after
infection with the R404BP virus
Because nitric oxide (NO) plays a pivotal role in cyto-
toxic activities and tissue damage during inflammatory
processes (Reiss and Komatsu, 1998), we investigated
brain slices for inducible nitric oxide synthase (iNOS)
and nitrotyrosine (NT), an in vitro marker of NO-derived
peroxynitrite. The immunohistochemistry did not detect
iNOS and NT in the normal brains. The iNOS induction
and nitration of tyrosine occurred in the virus-infected
areas of the brain as early as 5 days after infection with
105 PFU of the virus, involving vessels on occasion (Fig.
5). Overall, distribution of the virus, mononuclear cell
infiltration, iNOS, and NT coincided with each other. As
infection progressed with time (on days 7 and 9), such
vessels immunopositive for iNOS and NT increased in
frequency, and the destruction of vascular structures
manifested itself.
Systemic histopathological findings
The postmortem examination of the lungs of virus-
infected mice showed mild alveolar hemorrhage without
obvious inflammatory response. The heart, liver, kidney,
and adrenal glands appeared congested. Representative
lymphoid organs, including the thymus, spleen, and mes-
enteric lymph nodes, became atrophic and exhibited a
number of apoptotic bodies. However, the polymerase
chain reaction did not detect the influenza virus matrix
gene in the blood samples collected on days 3, 6, and 9
after infection. The immunohistochemistry did not detect
viral antigens in these organs collected on days 5, 7, and
9. These results suggest the absence of hematogenous
dissemination of the virus during the course of the CNS
infection.
Protective and therapeutic effects of amantadine
hydrochloride
In an attempt to protect mice against the lethal acute
encephalitis caused by the R404BP virus, we treated
FIG. 2. Diagram of the distribution of virally infected neurons in
anteroposterior coronal sections through the brain of C57BL/6 mice on
day 7 after microinjection with the R404BP virus into the right olfactory
bulb. Camera lucida illustrations show infected neurons, plotted at
various levels of the brain. Abbreviations: Amy, amygdaloid complex;
DR, dorsal raphe; HDB, nucleus of the horizontal limb of the diagonal
band; LC, locus coeruleus; LEnt, lateral entorhinal cortex; LM, lateral
mammillary nucleus; MEnt, medial entorhinal cortex; MHb, medial
habenular nucleus; MnR, median raphe nucleus; Pir, piriform cortex;
PMR, paramedian raphe nucleus; PnO, pontine reticular nucleus, oral;
PnR, raphe pontis; PV, paraventricular thalamic nucleus; Py, pyramidal
cell layer of the hippocampus; SNC, substantia nigra, compact; SNR,
substantia nigra, reticular; VTA, ventral tegmental area.
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mice with amantadine hydrochloride according to the
prophylactic and therapeutic regimens (Table 2). Intra-
peritoneal administration of amantadine (100 mg/kg)
transiently decreased motor activities of normal C57BL/6
mice as described previously (Messiha, 1989). The in-
crease of the dose of amantadine to 200 mg/kg killed
100% of the mice within 3 min (n  6). When mice were
challenged with 105 PFU of the R404BP virus, amanta-
dine administration based on the prophylactic regimen 1
(100 mg/kg, twice a day) did not confer protective effects
(Table 2). However, when mice were infected with 10 PFU
of the virus, treatment with the prophylactic regimen 1
completely protected mice against the acute encephali-
tis. No infected neurons appeared in the brain and all
mice survived the infection. The prophylactic regimen 2
(100 mg/kg, once a day) appeared slightly effective in
protecting mice against the acute encephalitis.
Therapeutic regimens 1 and 2 provided 100% survival
(Table 2), although a small number of neurons became
infected (Figs. 6A and 6B), displaying morphological al-
terations characteristic of apoptosis (Fig. 7A). The ther-
apeutic regimen 3 resulted in a survival effect with sta-
tistic significance, although numerous neurons were in-
fected (Fig. 6C). Therapeutic regimen 4 yielded no benefit
at all; it did not prevent death of the animals nor extend
FIG. 3. Photomicrographs illustrating brain structures heavily at-
tacked by the R404BP virus. (A) The mitral cell layer of the main
olfactory bulb. Arrows point to the R404BP virus-infected mitral neu-
rons. (B) Infected neurons (arrows), packed in a small area of the
indusium griseum (surrounded by the elliptic line). (C) Infected neurons
(arrows) in the nucleus of the horizontal limb of the diagonal band. (D)
Infected neurons (arrows) in the substantia nigra, compact. The scale
bar in (A) represents 10 m, common to (C) and (D), while that in (B)
indicates 20 m.
FIG. 4. Outcome of the CNS infection induced by the R404BP virus. (A) Confocal laser scanning microscopy of neurons in the anterior olfactory
nucleus on day 7 after infection with the R404BP virus, illustrating evidence of apoptosis. The virus-specific signal is shown as red, the TUNEL-specific
signal is shown as green, and the overlap of both as is shown as yellow. The scale bar represents 10 m. (B) Heavy neuronal loss found in the
MnR/PMR of the postmortem brain on day 10 after infection. Hematoxylin and eosin staining. The scale bar represents 50 m. (C) The postmortem
brain dissected from a mouse found dead on day 10 after infection. (D) The live brain obtained from a moribund mouse on day 10 after infection. The
scale bar in (D) represents 100 m, common to (C) and (D).
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MSD (therapeutic regimen 4, 11.8  0.8; PBS control,
12.4  0.7; shown as average  SEM).
Protective mechanism of the amantadine
administration against the lethal encephalitis
We have examined the relationship between virus in-
fection and NO-mediated nitration of proteins, especially
focusing on involvement of capillaries in the mouse
brain. When virally infected mice were treated according
to therapeutic regimens 1 and 2, the immunohistochem-
istry did not detect iNOS or NT (Fig. 7B) in the brain.
Inflammatory cell infiltration and brain edema were not
evident. When mice underwent therapy on the basis of
the therapeutic regimen 3, vascular structures remained
almost free from viral infection (Fig. 7C), iNOS, protein
nitration (Fig. 7D), and mononuclear cell infiltration.
Again, brain edema was not found in these mice. In
brains of virus-infected mice that were treated with PBS
instead of amantadine, where virus invasion, protein
nitration, and mononuclear cell infiltration appeared
prominent, destruction of capillary structures was evi-
dent (Figs. 7E and 7F). Postmortem brains on day 10
showed brain edema.
Neuronal loss in the brain of virus-infected mice
Neuronal loss on day 28 after infection was not evi-
dent in the brain of mice treated with prophylactic regi-
men 1 and therapeutic regimens 1 and 2 (Fig. 8A), while
with the therapeutic regimen 3 a number of neurons
disappeared from the brain (Fig. 8B).
FIG. 5. Detection of iNOS and NT in the brain on day 5 after infection
with the R404BP virus. In the VTA, a number of neurons became
infected (A). Infection involved the vessel wall as well as the brain
parenchyma. Detection of iNOS (B) and NT (C) in the corresponding
area of consecutive brain slices. The scale bar represents 10 m,
common to (A) and (C).
TABLE 2
Prophylactic and Therapeutic Administration of Amantadine Hydro-
chloride against the Lethal Encephalitis Induced by the R404BP Virus
Protocol
Virus inoculum
(log PFU)
Survival rate
(survivor/total)
Prophylactic regimen 1b 5 1/5 (0/5)a
Prophylactic regimen 1 1 5/5 (0/5) P  0.005c
Prophylactic regimen 2d 1 3/5 (0/5)
Therapeutic regimen 1e 1 5/5 (0/5) P  0.005
Therapeutic regimen 2 f 1 5/5 (0/5) P  0.005
Therapeutic regimen 3g 1 4/5 (0/5) P  0.05
Therapeutic regimen 4h 1 0/5 (0/5)
Control for amantadine toxicity i — 3/3
a Control mice were intraperitoneally injected with PBS instead of
amantadine hydrochloride solution.
b Prophylactic regimen 1: mice were intraperitoneally administered
amantadine hydrochloride solution (100 mg/kg) twice a day (every 12 h)
from day 1 (before infection) to day 11 after infection.
c Statistically significant by the Fisher’s exact probability test.
d Prophylactic regimen 2: mice were intraperitoneally administered
amantadine hydrochloride solution (100 mg/kg) once a day (every 24 h)
from day 1 to day 11 after infection.
e Therapeutic regimen 1: mice were intraperitoneally administered
amantadine hydrochloride (100 mg/kg) twice a day (every 12 h) from
day 1 to day 12 after infection.
f Therapeutic regimen 2: mice were intraperitoneally administered
amantadine hydrochloride (100 mg/kg) twice a day (every 12 h) from
day 4 to day 15 after infection.
g Therapeutic regimen 3: mice were intraperitoneally administered
amantadine hydrochloride (100 mg/kg) twice a day (every 12 h) from
day 7 to day 18 after infection.
h Therapeutic regimen 4: mice were intraperitoneally administered
amantadine hydrochloride (100 mg/kg) twice a day (every 12 h) from
day 10 to day 21 after infection.
i Uninfected mice were treated with amantadine hydrochloride ac-
cording to prophylactic regimen 1.
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DISCUSSION
The present study establishes that the recombinant
R404BP strain of influenza A virus presents an increased
neuroinvasiveness in the mouse brain compared with
the original WSN virus and that prophylactic and early
therapeutic administration of amantadine protects mice
against the lethal encephalitis induced by the R404BP
virus.
The recombinant virus infects most granule cells (in-
terneurons) and mitral cells (output neurons) in the main
olfactory bulb, which enables the virus to efficiently at-
tack a broad spectrum of targets which are directly
linked to the olfactory bulb through the axonal pathways.
It should be noted that there exists dense dentroden-
dritic synaptic interaction between granule and mitral
cells (Price and Powell, 1970), providing explanation for
the efficient viral transmission from granule to mitral
cells. Thus, infected neurons are distributed in areas
reciprocally connected to the olfactory bulb, such as the
anterior olfactory nucleus, tenia tecta, and entorhinal
cortices (Shipley and Adamek, 1984). Infection also
progresses to areas that receive the olfactory bulb effer-
ent, such as the indusium grisium (Adamek et al., 1984),
and areas that provide axonal projections to the olfactory
bulb, such as the diagonal band, dorsal raphe, and locus
coeruleus (Shipley and Adamek, 1984). Furthermore, the
virus infection extends to structures directly coupled with
some of the abovementioned primary targets, including
the ventral tegmental area, substantia nigra, and oral
pontine reticular nucleus (Oades and Halliday, 1987; Pas-
quier et al., 1977; Shammah-Lagnado et al., 1987). Thus,
the increased neurovirulence of the R404BP virus, com-
pared with the WSN virus, might be attributable to its
ability to perform efficient transsynaptic transmission in
the brain, as reported in herpes simplex and rabies
viruses (Dehal et al., 1993; Etessami et al., 2000). It
should be emphasized that selectivity of virus targeting
is still retained despite the increased neuroinvasive po-
tentiality of the virus. On the other hand, infection with
the R404BP virus frequently involves vessels where per-
oxynitrite-mediated protein nitration takes place, leading
to the disruption of the blood-brain barrier and the fatal
brain edema.
Amantadine represents influenza A virus-specific an-
tiviral action and has been used for prophylaxis and
treatment of influenza A virus infection of the respiratory
tract (Oxford and Galbraith, 1980). The primary antiviral
action of amantadine derives from blocking the H chan-
nel formed by the virion-associated M2 protein, prohib-
iting the flow of H from the acidified endosome into the
virion, an essential step for the release of the transcrip-
tionally active ribonucleoprotein complex into the cyto-
plasm, i.e., the uncoating process. Amantadine is trans-
ported principally across the cerebral capillaries by a
carrier-mediated transport system (Spector, 1988), which
makes it possible for this drug to exert its antiviral ac-
tions in the brain parenchyma following the intraperito-
neal administration. In our experimental system, aman-
tadine therapy primarily inhibits viral growth in the neu-
rons and consequently protects vessels from the
inflammatory damages. It is highly likely that such sec-
ondary vasoprotection conferred by the amantadine
treatment maintains the integrity of the blood-brain bar-
rier, hindering the occurrence of brain edema and death
of the animals.
The degree of neuronal depletion depends on the time
FIG. 6. Therapeutic effects of intraperitoneal administration of amantadine hydrochloride on the distribution of neurons infected with the R404BP
virus. Camera lucida illustrations show infected neurons, plotted at the level of SNC/VTA on day 10 after infection. Mice were treated with amantadine
according to therapeutic regimen 1 (A), therapeutic regimen 2 (B), and therapeutic regimen 3 (C). Control mice were injected with PBS instead of
amantadine solution (D).
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lag between the virus challenge and the start of aman-
tadine treatment. Amantadine appears to have no effect
on suppressing influenza virus infection, once the un-
coating step has proceeded in each neuron. Interest-
ingly, according to therapeutic regimens 1 and 2, inflam-
matory cells do not emerge in the brain regions where
virally infected apoptotic neurons remain during aman-
tadine treatment. In general, apoptosis does not result in
a loss of cellular contents into the extracellular space,
nor does it incite an inflammatory response, which
sharply contrasts with necrosis (Bredesen, 1995). How-
ever, amantadine administration at a later stage of infec-
tion, based on therapeutic regimen 3, cannot control the
progression of inflammation in the brain. Collectively,
early pharmacological intervention is definitely important
to minimize neuronal depletion due to the influenza virus
infection and accompanying inflammation in the CNS.
Sequence analysis of the RT-PCR-amplified M2 region
of influenza viruses revealed that amino acid sequence
of the R404BP virus (data not shown) is exactly identical
with that of the WSN strain, containing asparagine at
position 31 (Markushin et al., 1988). The amino acid
residue at this position plays a definite role in suscepti-
bility of the virus to the drug amantadine (Takeda et al.,
2002). The 50% inhibitory concentration of amantadine
for the R404BP virus growth in MDCK cells in vitro was
calculated as 1 g/ml that indicates the virus strain used
in the present study is less susceptible to the drug. It
might be expected that more promising prophylactic and
therapeutic virtue of amantadine in vivo could be attained
in the case of infection with the ordinary drug-sensitive
strains of influenza virus.
The induction of iNOS, which brings about overpro-
duction of NO, may be beneficial to host defense against
bacteria and parasites (James, 1995; Umezawa et al.,
1997). Likewise, the expression of iNOS has been doc-
umented in various viral infections, the significance of
which still remains unsettled. Viruses can be both sen-
sitive or resistant to the antiviral effects of NO, demon-
strated in in vitro and in vivo experimental systems (Reiss
and Komatsu, 1998). On the other hand, overproduction
of NO, especially its oxidized intermediate, peroxynitrite,
has been implicated in the pathophysiology of numerous
inflammatory diseases (Morikawa et al., 1999). Peroxyni-
trite is a highly reactive chemical that causes nitration
and hydroxylation of tyrosine and tryptophan, as well as
DNA injury. Administration of a competitive NOS inhibi-
tor, L-NMMA, resulted in amelioration of influenza virus-
induced pneumonia, suggesting a role of NO in viral
pathogenesis (Akaike et al., 1996). Thus, it could be
interesting to investigate the pathological significance of
iNOS induced in the brain after infection with the R404BP
virus by manipulating NOS with its inhibitors and by
using iNOS-deficient mice. Intriguingly, NO exerts both
proapoptotic and antiapoptotic functions (Billiar, 2000).
Roles played by NO in modulating cell viability should be
investigated in this experimental system.
MATERIALS AND METHODS
Experimental virus-animal system
Specific pathogen-free female C57BL/6 mice, at the
age of 4 weeks, were used for the experiments (Clear
Japan, Osaka, Japan). The R404BP strain of recombinant
influenza A virus was a kind gift from Dr. Setsuko Naka-
jima (The Institute of Public Health, Tokyo, Japan). The
virus possesses the neuraminidase and matrix genes
from the WSN virus (H1N1) and the rest from the non-
neurovirulent A/Aichi/2/68 strain (H3N2). The original re-
combinant virus (R404 virus) had been passaged suc-
cessively in the mouse brain and then a highly neuro-
virulent strain (R404BP virus) was isolated. Stereotaxic
microinjection of the virus into the olfactory bulb was
carried out as described previously (Mori et al., 1999).
Infected mice were clinically and histopathologically
monitored daily after infection. An MSD was calculated
according to the formula: MSD  ¥ [ f(d  1)]/N, where
f is the number of mice recorded dead on day d and N is
the number of mice in a group (Grunert et al., 1965). For
virus inactivation, the virus suspension was exposed to a
15 W ultraviolet lamp at a distance of 15 cm at 4°C for 30
min with continuous and gentle stirring. After irradiation,
infectivity was reduced to 107 of the original.
Tissue processing and immunohistochemistry
The animals were anesthetized with an overdose of
7.2% chloral hydrate in phosphate-buffered saline (PBS)
and perfused transcardially with 3.7% formaldehyde in
PBS. The brains were removed, soaked in 15% sucrose
in PBS at 4°C overnight, and frozen at 80°C. Coronal
sections were cut at 14-m-thickness on a cryostat.
Postmortem organs were paraffin-embedded and cut on
a microtome. Immunohistochemistry was performed as
reported previously (Mori and Kimura, 2000) by using the
rabbit polyclonal anti-WSN virus antibody (a generous
gift from Dr. Setsuko Nakajima, The Institute of Public
Health, Tokyo, Japan), rabbit polyclonal anti-iNOS anti-
body (Upstate Biotechnology, Lake Placid, NY; working
concentration, 5 g/ml), and rabbit polyclonal anti-nitro-
tyrosine antibody (Upstate Biotechnology; working con-
centration, 20 g/ml). Goat anti-rabbit immunoglobulins
conjugated to peroxidase-labeled dextran polymer in
Tris–HCl buffer (DAKO Envision, DAKO, Carpinteria,
CA) was adopted as a secondary antibody.
Detection of apoptosis
Morphological alterations characteristic of apoptosis
were investigated by the cresyl violet staining method.
DNA fragmentation was detected in situ by the TUNEL
method using an Apoptag Direct in situ apoptosis detec-
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FIG. 7. Vascular histopathology of mice suffering from acute encephalitis induced by the R404BP virus. Mice were treated with the drug according
to therapeutic regimen 1 (A and B) and therapeutic regimen 3 (C and D). Control mice received PBS (E and F). Brain slices were immunostained for
virus antigens (A, C, and E) and for nitrotyrosine (B, D, and F). All samples were taken on day 10 after infection. The asterisks indicate vessel lumens.
The scale bar represents 10 m, common to A to F.
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tion kit (Oncor, Gaithersburg, MD) as described in the
previous article (Mori and Kimura, 2000).
Detection of the influenza virus gene
Total RNA was extracted from the blood samples by
using the TRIZOL Reagent (Invitrogen, Carlsbad, CA).
Glycogen (Invitrogen) was added to the samples to pro-
mote RNA precipitation. The cDNA synthesis and the
successive polymerase chain reaction (PCR) were car-
ried out with SUPERSCRIPT One-Step RT-PCR with PLAT-
INUM Taq System (Invitrogen) according to the manufac-
turer’s instructions with modifications. The cDNA was
generated at 50°C for 30 min with the sense primer
(5-GAGATCGCACAGAGA-3) (Urabe et al., 1993). Then,
the antisense primer (5-TCGTTGCATCTGCAC-3) (Urabe
et al., 1993) was added into the reverse transcription
product. The PCR was performed with the schedule of
94°C for 3 min followed by 35 cycles of 94°C for 30 s,
56°C for 30 s, and 72°C for 1 min. The final products
were differentiated on 1% agarose gel, stained with
ethidium bromide, and visualized under an ultraviolet
lamp.
Administration of amantidine
Amantadine hydrochloride (Sigma, St. Louis, MO) was
intraperitoneally injected into the mice at a concentration
of 10 mg/ml in sterile water, according to the protocol for
the prophylactic and therapeutic regimens (Table 2).
Mice were observed clinically and subjected to his-
topathological investigations after the virus challenge.
The concentration of amantadine that causes a 50%
inhibition of the R404BP virus growth in MDCK cells in
vitro was 1 g/ml.
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